Toshiyuki Shirai, Satoshi Okazaki, Takaki Tanifuji, Shusuke Numata, Tomohiko Nakayama, Tomohiro Yoshida, Kentaro Mouri, Ikuo Otsuka, Noboru Hiroi, Akitoyo Hishimoto. Meta-analyses of epigenetic age acceleration and GrimAge components of schizophrenia or first-episode psychosis. Schizophrenia (Heidelberg, Germany). 2024. 10. 1. 108-108
Toshinori Nakamura, Ryuji Furihata, Naomi Hasegawa, Fumitoshi Kodaka, Hiroyuki Muraoka, Kayo Ichihashi, Shinichiro Ochi, Shusuke Numata, Takashi Tsuboi, Manabu Makinodan, et al. The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study. BMC psychiatry. 2024. 24. 1. 399-399
Tomoya Takeda, Masahito Nakataki, Hidehiro Umehara, Shusuke Numata. Associations between negative and positive automatic thoughts and clinical variables in patients with schizophrenia. Schizophrenia Research: Cognition. 2024. 35. 100298-100298
Hirotaka Yamagata, Yuko Fujii, Shinichiro Ochi, Tomoe Seki, Naomi Hasegawa, Hisashi Yamada, Hikaru Hori, Kayo Ichihashi, Jun ichi Iga, Kazuyoshi Ogasawara, et al. Effect of the guideline education program on anticholinergic and benzodiazepine use in outpatients with schizophrenia and major depressive disorder: The effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE) project. Psychiatry Research Communications. 2024. 4. 1
Tomoya Takeda, Hidehiro Umehara, Yui Matsumoto, Tomohiro Yoshida, Masahito Nakataki, Shusuke Numata. Schizophrenia and cognitive dysfunction. The Journal of Medical Investigation. 2024. 71. 3.4. 205-209
*Shinichiro Ochi, Fumitoshi Kodaka, Naomi Hasegawa, Jun-Ichi Iga, Hiroko Kashiwagi, Hiroshi Komatsu, Hiromi Tagata, Takashi Tsuboi, Shusuke Numata, Hitoshi Iida, et al. ASSOCIATIONS OF CLOZAPINE AVAILABLE INSTITUTION AND THE DIAGNOSIS OF SUBGROUPS ABOUT TREATMENT-RESISTANT SCHIZOPHRENIA OR NOT WITH A HIGHER RATE OF ANTIPSYCHOTIC MONOTHERAPY AND LOWER OTHER CONCOMITANT PSYCHOTROPICS IN OVERALL SCHIZOPHRENIA TREATMENT: A REAL-WORLD NATIONWIDE STUDY. International Journal of Neuropsychopharmacology. 2025. 28. Supplement_1. i163-i164
2013/06 - World Congress of Biological Psychiatry Young Scientist Award
2012/09 - 日本生物学的精神医学会 若手研究者育成プログラム奨励賞
2012/03 - 日本統合失調症学会 一般演題優秀賞
Association Membership(s) (7):
JAPANESE PSYCHOGERIATRIC SOCIETY
, 日本神経精神薬理学会
, Japanese Society of Mood Disorders
, 日本臨床精神神経薬理学会
, 日本統合失調症学会
, JAPANESE SOCIETY OF BIOLOGICAL PSYCHIATRY
, 日本精神神経学会